Clinical Trials Browser

OTHER_GOV × endostar protein × Thoracic × Clear all

NCT06617936 2025-07-15

Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.

Phase 2 Recruiting

Unresectable Non-small Cell Lung Cancer

NCT06618391 2024-10-01

Local Injection and Systemic Therapy in the Treatment of NSCLC.

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT02804646 2016-06-21

Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma

Phase 4 Unknown

Adenocarcinoma of Lung